| Sources | Names Used |
|---|---|
| GDSC1000 | HG-5-88-01 |
| PharmacoGx | HG-5-88-01 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FBXO22 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | ADCY6 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | IQCE | GDSC1000 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | GUK1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | RNF223 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | C16orf58 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | NUBP2 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | PLXNB1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | SCYL2 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | SIK3 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.09 |
